Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016
Publisher Name » IMARC
Published Date » 2012-01-20
No. Of Pages » 78
Advancements in antibody technology has revolutionized both the diagnostic and therapeutic sciences. As of today, monoclonal antibodies can be produced virtually against any antigen and they have transformed the diagnostic industry in view of their specificity towards specific antigens and almost unlimited production capabilities. In the field of therapeutics, they have changed the treatment possibilities and significantly improved the life expectancies of patients who were earlier having very high unmet needs.
IMARC Group, one of the world’s leading research and advisory firms, in its latest report “Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016” finds that the Indian market for both therapeutic and diagnostic antibodies is expected to grow exponentially in the coming years. Findings from the report suggest that more than 60% of the total antibodies market is currently dominated by diagnostic antibodies. This segment, however, is more mature, has lower entry barriers and is extremely price sensitive. The market for therapeutic antibodies in India, on the other hand, is still in its infancy and more than half of the globally launched therapeutic monoclonal antibodies are currently not even available here. In the coming years, however, we expect this market to explode. Driven by a continuous increase in healthcare expenditures, increasing affordability, and a number of new product launches, we expect the market for therapeutic antibodies to grow at a CAGR of 27% in the next five years.
IMARC’s new report entitled “Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016” provides an analytical and statistical insight into the Indian Antibodies market. The study, that has been undertaken using desk-based as well as qualitative primary research, provides and draws upon analysis of the following aspects of the Indian antibodies market.
Key Aspects Analyzed:
Diagnostic Antibodies
Understanding the strengths, weaknesses, opportunities and challenges in the Indian diagnostic antibodies market
Understanding the technological considerations and regulatory factors in the Indian diagnostic antibodies market
- Evaluating the various types of antibody based diagnostic tests conducted in India and analyzing their strengths and weaknesses
- Understanding the key regulations for registering, manufacturing and importing diagnostics in India
Segments covered: HIV, Hepatitis B, Hepatitis C, Tuberculosis, Dengue, Syphilis and Oncology
Focus of the analysis in each segment:
- Number of tests conducted each year
- Breakup by type of tests conducted
- Current and future market sales
- Average cost of diagnostic tests
- Key players operating in the market
Understanding the strengths, weaknesses, opportunities and challenges in the Indian therapeutic antibodies market
Understanding the technological considerations and regulatory factors in the Indian therapeutic antibodies market
- Evaluation and identification of monoclonal antibodies based on the sources from which they are derived and on the targets against which they act.
- Understanding the key regulations for registering, manufacturing and importing therapeutic antibodies in India.
- Identifying the patentee name and patent numbers of all in-market monoclonal antibodies in India, US and Europe
- Identifying the monoclonal antibodies that are patent protected in India, US and Europe and those that are not
- Estimating the patent expiries of various monoclonal antibodies in India, US and Europe.
- Analyzing current and future sales of monoclonal antibodies in India
- Identifying all globally launched monoclonal antibodies and understanding their performance and launch status in India
- Analyzing the global and Indian monoclonal antibodies market by Indication
- Evaluation of the top selling monoclonal antibodies
- Key biosimilar antibody development programmes in India and abroad
Table of Content
1 Market Definitions & Methodology
2 Executive Summary
3 Indian Antibodies Market
4 Antibody Based Diagnostics Market in India
4.1 Industry Analysis
4.1.1 Strengths
4.1.2 Weaknesses
4.1.3 Opportunities
4.1.4 Threats
4.2 Technological & Regulatory Assessment
4.2.1 Technological Assessment
4.2.2 Regulatory Assessment
4.3 Market Analysis
4.3.1 Current & Future Sales Trends
4.3.2 Market Segments by Usage
4.3.2.1 HIV Diagnostics: Current Trends & Forecast
4.3.2.2 Hepatitis B Diagnostics: Current Trends & Forecast
4.3.2.3 Hepatitis C Diagnostics: Current Trends & Forecast
4.3.2.4 Tuberculosis Diagnostics: Current Trends & Forecast
4.3.2.5 Dengue Diagnostics: Current Trends & Forecast
4.3.2.6 Pregnancy Diagnostics: Current Trends & Forecast
4.3.2.7 Syphilis Diagnostics: Current Trends & Forecast
4.3.2.8 Oncology Diagnostics: Current Trends & Forecast
5 Therapeutic Antibodies Market in India
5.1 Industry Analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2 Technological & Regulatory Assessment
5.2.1 Technological Assessment
5.2.2 Regulatory Assessment
5.3 Patent Details of Various Monoclonal Antibodies: US, Europe & India
5.4 Market Analysis
5.4.1 Current & Future Sales Trends
5.4.2 Sales Breakup by Molecule
5.4.3 Sales by Indication
5.5 Evaluation of Top Monoclonal Antibodies
5.5.1.1 Avastin
5.5.1.2 Herceptin
5.5.1.3 Rituxan/Mabthera
5.5.1.4 Remicade
5.5.1.5 Humira
5.6 Biosimilar Case Studies
5.6.1 Reditux
5.6.2 Grafeel
5.7 Key Indian & Foreign Biosimilar Antibody Development Programmes
Table 1 1: Monoclonal Antibodies Market: Market Definitions
Table 1 2: India - Immunodiagnostics Market: Market Definitions
Table 2 1: India - Diagnostic Antibodies Market - SWOT Analysis
Table 2 2: India - Executive Summary - Immunodiagnostics Market: Overview of Various Indications, 2010
Table 2 3: India - Therapeutic Antibodies Market - SWOT Analysis
Table 4 1: India - Statistics of Various Indications
Table 4 2: India - Comparison of Rapid & Elisa Tests
Table 4 3: India - Immunodiagnostics Market: Overview of Various Indications, 2010
Table 4 4: India - HIV Diagnostics Market: Key Statistics, 2010
Table 4 5: India - Hepatitis B Diagnostics Market: Key Statistics, 2010
Table 4 6: India - Hepatitis C Diagnostics Market: Key Statistics, 2010
Table 4 7: India - Tuberculosis Diagnostics Market: Key Statistics, 2010
Table 4 8: India - Cancer Diagnostics Market: Overview of Various Cancer Markers
Table 5 1: Globally Launched Monoclonal Antibodies & Their Targets
Table 5 2: US, Europe & India - Patent Details of Various Monoclonal Antibodies
Table 5 3: Global & Indian: Monoclonal Antibodies Market - Statistics of Various Brands
Table 5 4: India - Monoclonal Antibodies Market: Sales of Top Selling Molecules (in INR Million), 2010
Table 5 5: Drug Overview: Avastin
Table 5 6: Drug Overview: Herceptin
Table 5 7: Drug Overview: Rituxan
Table 5 8: Drug Overview: Remicade
Table 5 9: Drug Overview: Humira
Table 5 10: Drug Overview: Reditux
Table 5 11: Companies Developing Herceptin (Trastuzumab) Biosimilars
Table 5 12: Companies Developing Remicade (Infliximab) Biosimilars
Table 5 13: Companies Developing Mabthera (Rituximab) Biosimilars
Table 5 14: Companies Developing Humira (Trastuzumab) Biosimilars
Table 5 15: Companies Developing Other Monoclonal Antibody Biosimilars
Figure 3 1: India - Antibodies Market Forecast, 2010-2016
Figure 3 2: India - Antibodies Market Forecast - Breakup by Segment (in %), 2010-2016
Figure 4 1: India - Overview of Elisa and Rapid Tests
Figure 4 2: India - In-Vitro Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 3: India - Immunodiagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 4: India - Immunodiagnostics Market Forecast: Breakup by Indication (in %), 2010 & 2016
Figure 4 5: India - HIV Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 6: India - HIV Diagnostics Market: Volume Share by Lab (in %), 2010
Figure 4 7: India - HIV Diagnostics Market: Value & Volume Share of Various Tests (in %), 2010
Figure 4 8: India - Hepatitis B Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 9: India - Hepatitis B Diagnostics Market: Share of Various Tests (in %), 2010
Figure 4 10: India - Hepatitis C Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 11: India - Hepatitis C Diagnostics Market: Share of Various Tests (in %), 2010
Figure 4 12: India - Tuberculosis Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 13: India - Tuberculosis Diagnostics Market: Share of Various Tests (in %), 2010
Figure 4 14: India - Dengue Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 15: India - Dengue Diagnostics Market: Volume Share of Various Tests (in %), 2010
Figure 4 16: India - Pregnancy Market Forecast (in INR Million), 2010-2016
Figure 4 17: India - Syphilis Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 18: India - Syphilis Diagnostics Market: Volume Share of Various Tests (in %), 2010
Figure 4 19: India - Cancer Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 5 1: Monoclonal Antibodies Based on Their Sources
Figure 5 2: India - Approval Process for a New Drug
Figure 5 3: Global - Monoclonal Antibodies Market Forecast (in INR Million), 2010-2016
Figure 5 4: India - Monoclonal Antibodies Market Forecast (in INR Million), 2010-2016
Figure 5 5: Global - Monoclonal Antibodies Market: Sales Share by Molecule (in %), 2010
Figure 5 6: India - Monoclonal Antibodies Market: Sales Share by Molecule (in %), 2010
Figure 5 7: Global - Monoclonal Antibodies Market by Indication (in %), 2010
Figure 5 8: India - Monoclonal Antibodies Market by Indication (in %), 2010-2016
Figure 5 9: Global - Avastin Sales (in INR Million), 2006- 2010
Figure 5 10: Global - Avastin Sales Forecast (in INR Million), 2010-2016
Figure 5 11: Global - Herceptin Sales (in INR Million), 2006-2010
Figure 5 12: Global - Herceptin Sales Forecast (in INR Million), 2010-2016
Figure 5 13: Global - Rituxan/Mabthera Sales (in INR Million), 2006-2010
Figure 5 14: Global - Rituxan/Mabthera Sales Forecast (in INR Million), 2010-2016
Figure 5 15: Global - Remicade Sales (in INR Million), 2006-2010
Figure 5 16: Global - Remicade Sales Forecast (in INR Million), 2010-2016
Figure 5 17: Global - Humira Sales (in INR Million), 2006-2010
Figure 5 18: Global - Humira Sales Forecast (in INR Million), 2010-2016
Figure 5 19: India - Reditux Sales (in INR Million), 2007-08 - 2010-2011
Figure 5 20: India - Impact of Grafeel on G-CSF Market Size & Prices, 2000-01 - 2009-10
1 Market Definitions & Methodology
2 Executive Summary
3 Indian Antibodies Market
4 Antibody Based Diagnostics Market in India
4.1 Industry Analysis
4.1.1 Strengths
4.1.2 Weaknesses
4.1.3 Opportunities
4.1.4 Threats
4.2 Technological & Regulatory Assessment
4.2.1 Technological Assessment
4.2.2 Regulatory Assessment
4.3 Market Analysis
4.3.1 Current & Future Sales Trends
4.3.2 Market Segments by Usage
4.3.2.1 HIV Diagnostics: Current Trends & Forecast
4.3.2.2 Hepatitis B Diagnostics: Current Trends & Forecast
4.3.2.3 Hepatitis C Diagnostics: Current Trends & Forecast
4.3.2.4 Tuberculosis Diagnostics: Current Trends & Forecast
4.3.2.5 Dengue Diagnostics: Current Trends & Forecast
4.3.2.6 Pregnancy Diagnostics: Current Trends & Forecast
4.3.2.7 Syphilis Diagnostics: Current Trends & Forecast
4.3.2.8 Oncology Diagnostics: Current Trends & Forecast
5 Therapeutic Antibodies Market in India
5.1 Industry Analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2 Technological & Regulatory Assessment
5.2.1 Technological Assessment
5.2.2 Regulatory Assessment
5.3 Patent Details of Various Monoclonal Antibodies: US, Europe & India
5.4 Market Analysis
5.4.1 Current & Future Sales Trends
5.4.2 Sales Breakup by Molecule
5.4.3 Sales by Indication
5.5 Evaluation of Top Monoclonal Antibodies
5.5.1.1 Avastin
5.5.1.2 Herceptin
5.5.1.3 Rituxan/Mabthera
5.5.1.4 Remicade
5.5.1.5 Humira
5.6 Biosimilar Case Studies
5.6.1 Reditux
5.6.2 Grafeel
5.7 Key Indian & Foreign Biosimilar Antibody Development Programmes
List of Tables
Table 1 1: Monoclonal Antibodies Market: Market Definitions
Table 1 2: India - Immunodiagnostics Market: Market Definitions
Table 2 1: India - Diagnostic Antibodies Market - SWOT Analysis
Table 2 2: India - Executive Summary - Immunodiagnostics Market: Overview of Various Indications, 2010
Table 2 3: India - Therapeutic Antibodies Market - SWOT Analysis
Table 4 1: India - Statistics of Various Indications
Table 4 2: India - Comparison of Rapid & Elisa Tests
Table 4 3: India - Immunodiagnostics Market: Overview of Various Indications, 2010
Table 4 4: India - HIV Diagnostics Market: Key Statistics, 2010
Table 4 5: India - Hepatitis B Diagnostics Market: Key Statistics, 2010
Table 4 6: India - Hepatitis C Diagnostics Market: Key Statistics, 2010
Table 4 7: India - Tuberculosis Diagnostics Market: Key Statistics, 2010
Table 4 8: India - Cancer Diagnostics Market: Overview of Various Cancer Markers
Table 5 1: Globally Launched Monoclonal Antibodies & Their Targets
Table 5 2: US, Europe & India - Patent Details of Various Monoclonal Antibodies
Table 5 3: Global & Indian: Monoclonal Antibodies Market - Statistics of Various Brands
Table 5 4: India - Monoclonal Antibodies Market: Sales of Top Selling Molecules (in INR Million), 2010
Table 5 5: Drug Overview: Avastin
Table 5 6: Drug Overview: Herceptin
Table 5 7: Drug Overview: Rituxan
Table 5 8: Drug Overview: Remicade
Table 5 9: Drug Overview: Humira
Table 5 10: Drug Overview: Reditux
Table 5 11: Companies Developing Herceptin (Trastuzumab) Biosimilars
Table 5 12: Companies Developing Remicade (Infliximab) Biosimilars
Table 5 13: Companies Developing Mabthera (Rituximab) Biosimilars
Table 5 14: Companies Developing Humira (Trastuzumab) Biosimilars
Table 5 15: Companies Developing Other Monoclonal Antibody Biosimilars
List of Figures
Figure 3 1: India - Antibodies Market Forecast, 2010-2016
Figure 3 2: India - Antibodies Market Forecast - Breakup by Segment (in %), 2010-2016
Figure 4 1: India - Overview of Elisa and Rapid Tests
Figure 4 2: India - In-Vitro Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 3: India - Immunodiagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 4: India - Immunodiagnostics Market Forecast: Breakup by Indication (in %), 2010 & 2016
Figure 4 5: India - HIV Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 6: India - HIV Diagnostics Market: Volume Share by Lab (in %), 2010
Figure 4 7: India - HIV Diagnostics Market: Value & Volume Share of Various Tests (in %), 2010
Figure 4 8: India - Hepatitis B Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 9: India - Hepatitis B Diagnostics Market: Share of Various Tests (in %), 2010
Figure 4 10: India - Hepatitis C Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 11: India - Hepatitis C Diagnostics Market: Share of Various Tests (in %), 2010
Figure 4 12: India - Tuberculosis Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 13: India - Tuberculosis Diagnostics Market: Share of Various Tests (in %), 2010
Figure 4 14: India - Dengue Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 15: India - Dengue Diagnostics Market: Volume Share of Various Tests (in %), 2010
Figure 4 16: India - Pregnancy Market Forecast (in INR Million), 2010-2016
Figure 4 17: India - Syphilis Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 4 18: India - Syphilis Diagnostics Market: Volume Share of Various Tests (in %), 2010
Figure 4 19: India - Cancer Diagnostics Market Forecast (in INR Million), 2010-2016
Figure 5 1: Monoclonal Antibodies Based on Their Sources
Figure 5 2: India - Approval Process for a New Drug
Figure 5 3: Global - Monoclonal Antibodies Market Forecast (in INR Million), 2010-2016
Figure 5 4: India - Monoclonal Antibodies Market Forecast (in INR Million), 2010-2016
Figure 5 5: Global - Monoclonal Antibodies Market: Sales Share by Molecule (in %), 2010
Figure 5 6: India - Monoclonal Antibodies Market: Sales Share by Molecule (in %), 2010
Figure 5 7: Global - Monoclonal Antibodies Market by Indication (in %), 2010
Figure 5 8: India - Monoclonal Antibodies Market by Indication (in %), 2010-2016
Figure 5 9: Global - Avastin Sales (in INR Million), 2006- 2010
Figure 5 10: Global - Avastin Sales Forecast (in INR Million), 2010-2016
Figure 5 11: Global - Herceptin Sales (in INR Million), 2006-2010
Figure 5 12: Global - Herceptin Sales Forecast (in INR Million), 2010-2016
Figure 5 13: Global - Rituxan/Mabthera Sales (in INR Million), 2006-2010
Figure 5 14: Global - Rituxan/Mabthera Sales Forecast (in INR Million), 2010-2016
Figure 5 15: Global - Remicade Sales (in INR Million), 2006-2010
Figure 5 16: Global - Remicade Sales Forecast (in INR Million), 2010-2016
Figure 5 17: Global - Humira Sales (in INR Million), 2006-2010
Figure 5 18: Global - Humira Sales Forecast (in INR Million), 2010-2016
Figure 5 19: India - Reditux Sales (in INR Million), 2007-08 - 2010-2011
Figure 5 20: India - Impact of Grafeel on G-CSF Market Size & Prices, 2000-01 - 2009-10
Upcoming Reports:
|
Unsaturated Polyester Resin Market - Global Industry Analysis, Size, Share, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
A class of polyesters used in composite materials, which comprises approximately 80% of the total thermoset resins, is unsaturated polyester resin which is commonly referred to as UPR. The growing demand for UPR from end use industries is expected to drive its demand over the next five years. During the recession of 2009-2010, all the major industries across the globe experienced an adverse effect due to the economic downturn which included the UPR industry as well. Owing to the economic meltdown during that period, the major companies operating in the global market of UPR...
|
|
Fermentation Chemicals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Fermentation is natural process in which microorganisms breakdown the carbohydrates into alcohol or an acid. These carbohydrates can be starch or sugar. Fermentation chemicals are the chemicals produced out of fermentation process and act as direct agents to initiate the desired process. There are several processes where fermentation chemicals are the base for raw material breakdown or a part of process initiators.
Manufacturing of alcohol, cheese, breads, biogas and acids are some of the main industrial applications.Fermentation chemicals market has a huge potential to...
|
|
Medical Device Coatings Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Medical device coatings are widely used to augment product surface function and to improve performance. Coatings help in reducing friction between devices and tissues, and provide excellent surface coverage, wetting, uniform adhesion, wear-resistance and coating homogeneity. Many medical devices require non-stick coatings over moulded, electrical insulation, biocompatible, or other finishes. The global medical device coatings market will increase from $4.7 billion in 2009 to $7.5 billion in 2014, with a compound annual growth rate (CAGR) of 9.9%. The implant device market...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- Bed Linen Markets in the World to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Eastern Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Western Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Asia to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Americas to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Africa to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 10 Global Countries to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 5 European Countries to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 5 Asian countries to 2017 - Market Size, Trends, and Forecasts
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
